Antonio Linares
Publishes 1 feed
Investment Ideas by Antonio
Early AMD and Tesla investor, with a 2,500% return since 2014. Gain insights into my research process by reading my deep dives. One free deep dive per month. Deep dive updates for paid subscribers only.
20 posts · theirs
Lately
NervGen's Future.
They Were Paralyzed. Then They Joined a Peptide Trial.
Erectile dysfunction is now just a code bug
Caris Life Sciences: the Deepest Data in Oncology
NervGen: Chasing Ozempic for the Nervous System.
Hims vs Tempus AI
Tempus AI: Palantir With a Lab Coat.
Recursion Pharmaceuticals: The Drug Factory That Designs Itself
MiNK Therapeutics: One Cell. Every Disease. The $50M Company Hiding in Plain Sight.
Robotaxi, Optimus, and Terafab compound on a cash engine that never slowed.
Nvidia: The Faith Trade is Over
Palantir: My Next 100 Bagger.
Everything on this page was read from markup Antonio Linares published — a rel="me" link, an h-card, or the feed’s own author element. Nothing was inferred from anywhere else. To correct or remove it, get in touch. Machine-readable: JSON
